The 2017 Access to Vaccines Index compared what 8 vaccine manufacturers and developers are doing to help improve immunisation coverage. Its assessment is based on a framework of 13 metrics across three Research Areas. Here you find the three key findings: related to R&D for vaccine adaptations, vaccine pricing, and aligning supply and demand.

Got a question?

Learn more

View our detailed overview of each company’s performance in the Index